STERIS Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 5/13/2026)
| Balance Sheet | Total Assets | 10,737,200,000.00 | ROE | 67.03 % |
| Balance Sheet | Total Equity | 7,197,200,000.00 | ROA | 7.29 % |
| Cashflow | Capital Expenditures | -369,000,000.00 | P/FCF | 21.99 |
| Cashflow | Free Cash Flow | 972,400,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,341,400,000.00 | P/CF | 15.94 |
| Income | Earnings per Share (diluted) | 7.95 | Div. Yield | 1.13 % |
| Income | Net Income | 782,300,000.00 | P/E | 27.33 |
| Income | Shares Outstanding | 98,400,000.00 | P/B | 2.97 |
| Income | Total Revenue | 5,935,900,000.00 | P/S | 3.60 |
Ratios calculated on: 10/14/2026
Company Description
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.steris.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more